A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene

Journal of Molecular Diagnostics

Volumn 14, Issue 4, 2012, Pages 305-313

  Tan, Ying Cai ^a   Michaeel, Alber ^a   Blumenfeld, Jon ^a,b   Donahue, Stephanie ^b   Parker, Tom ^b   Levine, Daniel ^b   Rennert, Hanna ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROGOSIN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCYSTIN 1;

ACCURACY; ARTICLE; CLINICAL ARTICLE; EXON; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; KIDNEY POLYCYSTIC DISEASE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

FEMALE; GENETIC TESTING; HUMANS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYMERASE CHAIN REACTION; TRPP CATION CHANNELS;

EID: 84862685238     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.02.007     Document Type: Article

References (23)

1. Dalgaard OZ: Bilateral polycystic disease of the kidneys: a follow-up of 284 patients and their families. Dan Med Bull 1957, 4:128-133
2. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease: Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983, 2:630-639
3. Peters DJ, Sandkuijl LA: Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 1992, 97:128-139
4. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009, 76:149-168
5. Braun WE: Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments. Cleve Clin J Med 2009, 76:97-104
6. Harris PC, Torres VE: Polycystic kidney disease. Annu Rev Med 2009, 60:321-337
7. Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS: Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol 2006, 1:710-717
8. Blumenfeld JD: Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation 2009, 87:6-7
9. International Polycystic Kidney Disease Consortium: Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995, 81:289-298
10. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995, 10:151-160
11. Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, Roy S, Bakkaloglu A, Komel R, Winearls CG, Harris PC: Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet 2001, 68:46-63
12. Tan YC, Blumenfeld JD, Anghel R, Donahue S, Belenkaya R, Balina M, Parker T, Levine D, Leonard DG, Rennert H: Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat 2009, 30:264-273
13. den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000, 15:7-12
14. Kirsch S, Pasantes J, Wolf A, Bogdanova N, Munch C, Markoff A, Pennekamp P, Krawczak M, Dworniczak B, Schempp W: Chromosomal evolution of the PKD1 gene family in primates. BMC Evol Biol 2008, 8:263
15. Quinlan AR, Marth GT: Primer-site SNPs mask mutations. Nat Methods 2007, 4:192
16. Majewski J, Ott J: Distribution and characterization of regulatory elements in the human genome. Genome Res 2002, 12:1827-1836
17. Wang K, Zhao X, Chan S, Cil O, He N, Song X, Paterson AD, Pei Y: Evidence for pathogenicity of atypical splice mutations in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2009, 4:442-449
18. Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengut S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P: Splicing defects in the ataxia-telangiectasia gene: ATM: underlying mutations and consequences. Am J Hum Genet 1999, 64:1617-1631
19. Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X: Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 2000, 9:237-247
20. Rossetti S, Chauveau D, Walker D, Saggar-Malik A, Winearls CG, Torres VE, Harris PC: A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 2002, 61:1588-1599
21. Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA: Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol 2009, 10:R32
22. Lin J, Kennedy SH, Svarovsky T, Rogers J, Kemnitz JW, Xu A, Zondervan KT: High-quality genomic DNA extraction from formalinfixed and paraffin-embedded samples deparaffinized using mineral oil. Anal Biochem 2009, 395:265-267
23. Mc Sherry EA, Mc Goldrick A, Kay EW, Hopkins AM, Gallagher WM, Dervan PA: Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles. Clin Genet 2007, 72:441-447